Peter C. Ray

1.2k citations

21 papers · 556 indexed · h-index 12

Impact in

Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria

Papers in ⓘ

Infectious Diseases 8
- Tuberculosis Research and Epidemiology 8
Organic Chemistry 8
- Asymmetric Synthesis and Catalysis 4
- Synthetic Organic Chemistry Methods 3
- Chemical Synthesis and Reactions 2

Co-authors: Paul G. Wyatt (9 shared papers)Clifton E. Barry (6 shared papers)Helena I. Boshoff (6 shared papers)Sophie Pelletier (2 shared papers)Darren J. Dixon (2 shared papers)Simon R. Green (5 shared papers)Justin R. Harrison (1 shared paper)Qinglan Wang (1 shared paper)
Journals: Tetrahedron Letters (4 papers)ACS Infectious Diseases (3 papers)Bioorganic & Medicinal Chemistry (2 papers)Organic Letters (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
Partner nations: United Kingdom United States South Africa

In The Last Decade

Peter C. Ray

20 papers receiving 544 citations

Peers

Countries citing papers authored by Peter C. Ray

Since Specialization

Citations

This map shows the geographic impact of Peter C. Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Ray more than expected).

Fields of papers citing papers by Peter C. Ray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Ray. The network helps show where Peter C. Ray may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter C. Ray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter C. Ray Line = papers co-authored together Peter C. Ray links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis Science ·Qinglan Wang, Helena I. Boshoff, Justin R. Harrison, Peter C. Ray, Simon R. Green, Paul G. Wyatt, Clifton E. Barry	2020	124
2	Prediction of Drug Penetration in Tuberculosis Lesions ACS Infectious Diseases ·Jansy P. Sarathy, Fabio Zuccotto, Hsinpin Ho, Lars Sandberg, Laura E. Via, Gwendolyn A. Marriner, Thierry Masquelin, Paul G. Wyatt, Peter C. Ray, Véronique Dartois	2016	102
3	Respiratory Flexibility in Response to Inhibition of Cytochrome c Oxidase in Mycobacterium tuberculosis Antimicrobial Agents and Chemotherapy ·Kriti Arora, Bernardo Ochoa‐Montaño, Patricia Tsang, Tom L. Blundell, Stephanie S. Dawes, Valerie Mizrahi, Tracy Bayliss, Claire J. Mackenzie, Laura A. T. Cleghorn, Peter C. Ray, Paul G. Wyatt, Eugene Uh, Jinwoo Lee, Clifton E. Barry, Helena I. Boshoff	2014	95
4	Nitro-Mannich/Lactamization Cascades for the Direct Stereoselective Synthesis of Pyrrolidin-2-ones Organic Letters ·Sophie Pelletier, Peter C. Ray, Darren J. Dixon	2009	45
5	Fragment library design, synthesis and expansion: nurturing a synthesis and training platform Drug Discovery Today ·Peter C. Ray, Michael Kiczun, Margaret Huggett, Andrew Lim, Federica Prati, Ian H. Gilbert, Paul G. Wyatt	2016	30
6	Diastereoselective Synthesis of 1,3,5-Trisubstituted 4-Nitropyrrolidin-2-ones via a Nitro-Mannich/Lactamization Cascade Organic Letters ·Sophie Pelletier, Peter C. Ray, Darren J. Dixon	2011	22
7	Overcoming intrinsic diastereoselection using polyleucine as a chiral epoxidation catalyst Tetrahedron Letters ·Peter C. Ray, Stanley M. Roberts	1999	20
8	Optimisation of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors Bioorganic & Medicinal Chemistry Letters ·Peter C. Ray, Jane Wright, Julia Adam, Sylviane Boucharens, Darcey Black, Angus R. Brown, Ola Epemolu, Daniel A. Fletcher, Margaret Huggett, Phil Jones, Steven Laats, Amanda Lyons, Jos de Man, Richard Morphy, Brad Sherborne, Lorcan Sherry, Nicole van Straten, Paul Westwood, Mark York	2010	18
9	Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA ChemMedChem ·Federica Prati, Fabio Zuccotto, Daniel A. Fletcher, M.A. Convery, Raquel Fernández Menéndez, Robert H. Bates, Lourdes Encinas, Jingkun Zeng, Chun‐wa Chung, Paco De Dios Anton, Alfonso Mendoza‐Losana, Claire J. Mackenzie, Simon R. Green, Margaret Huggett, David Barros, Paul G. Wyatt, Peter C. Ray	2018	14
10	Structure–Activity Relationships of Pyrazolo[1,5-a]pyrimidin-7(4H)-ones as Antitubercular Agents ACS Infectious Diseases ·Sangmi Oh, M. Daben J. Libardo, Shaik Azeeza, Gary T. Pauly, José Santinni Roma, Andaleeb Sajid, Yoshitaka Tateishi, Caroline J. Duncombe, Michael Goodwin, Thomas R. Ioerger, Paul G. Wyatt, Peter C. Ray, David W. Gray, Helena I. Boshoff, Clifton E. Barry	2021	13
11	Juliá–Colonna stereoselective epoxidation of some α,β-unsaturated enones possessing a stereogenic centre at the γ-position: synthesis of a protected galactonic acid derivative Journal of the Chemical Society Perkin Transactions 1 ·Peter C. Ray, Stanley M. Roberts	2001	11
12	Synthesis of hexahydro[2]benzopyrano[3,4-c]pyrroles as serotonin 5-HT2C receptor agonists via intramolecular hetero Diels–Alder reactions Tetrahedron Letters ·Takao Kiyoi, Mark Reid, Stuart Francis, Keneth Davies, Steven Laats, Duncan McArthur, Anna-Marie Easson, Yasuko Kiyoi, Gary Tarver, Wilson Caulfield, Kirsty F. Gibson, Grant Wishart, Angus J. Morrison, Julia M. Adam, Peter C. Ray	2011	11
13	Resistance of Mycobacterium tuberculosis to indole 4-carboxamides occurs through alterations in drug metabolism and tryptophan biosynthesis Cell chemical biology ·M. Daben J. Libardo, Caroline J. Duncombe, Simon R. Green, Paul G. Wyatt, Stephen Thompson, Peter C. Ray, Thomas R. Ioerger, Sangmi Oh, Michael Goodwin, Helena I. Boshoff, Clifton E. Barry	2021	9
14	Functionalised 2,3-dimethyl-3-aminotetrahydrofuran-4-one and N-(3-oxo-hexahydrocyclopenta[b]furan-3a-yl)acylamide based scaffolds: synthesis and cysteinyl proteinase inhibition Bioorganic & Medicinal Chemistry ·John P. Watts, Alex Benn, Nick Flinn, Tracy Monk, Manoj K. Ramjee, Peter C. Ray, Yikang Wang, Martin Quibell	2004	9
15	Inhibition of CorA-Dependent Magnesium Homeostasis Is Cidal in Mycobacterium tuberculosis Antimicrobial Agents and Chemotherapy ·Yumi Park, Yong-Mo Ahn, Surendranadha Reddy Jonnala, Sangmi Oh, Julia M. Fisher, Michael Goodwin, Thomas R. Ioerger, Laura E. Via, Tracy Bayliss, Simon R. Green, Peter C. Ray, Paul G. Wyatt, Clifton E. Barry, Helena I. Boshoff	2019	9
16	Synthesis and evaluation of cis-hexahydropyrrolo[3,2-b]pyrrol-3-one peptidomimetic inhibitors of CAC1 cysteinyl proteinases Bioorganic & Medicinal Chemistry ·Martin Quibell, Alex Benn, Nick Flinn, Tracy Monk, Manoj K. Ramjee, Peter C. Ray, Yikang Wang, John P. Watts	2004	8
17	Targeting Mycobacterium tuberculosis CoaBC through Chemical Inhibition of 4′-Phosphopantothenoyl-l-cysteine Synthetase (CoaB) Activity ACS Infectious Diseases ·Joanna C. Evans, Dinakaran Murugesan, John Post, V. Mendes, Zhe Wang, Navid Nahiyaan, Sasha Lynch, Stephen Thompson, Simon R. Green, Peter C. Ray, Jeannine Hess, Christina Spry, Anthony G. Coyne, Chris Abell, Helena I. Boshoff, Paul G. Wyatt, Kyu Y. Rhee, Tom L. Blundell, Clifton E. Barry, Valerie Mizrahi	2021	6
18	Liver X receptor agonists as a treatment for atherosclerosis Expert Opinion on Therapeutic Patents ·David Jonathan Bennett, Andrew Cooke, Andrew S. Edwards, Elizabeth M. Moir, Peter C. Ray	2004	5
19	Synthesis of hexahydro[2]benzopyrano[4,3-c]pyridines as serotonin 5-HT2C receptor agonists via intramolecular hetero Diels–Alder reactions Tetrahedron Letters ·Yasuko Kiyoi, Steven Laats, Takao Kiyoi, Grant Wishart, Angus R. Brown, Peter C. Ray	2011	3
20	Stereoselective synthesis of tetrahydro-2H-[2]benzopyrano[3,4-c]pyrrol-3-ones and related compounds as precursors of serotonin 5-HT2C receptor agonists Tetrahedron Letters ·Stuart Francis, Takao Kiyoi, Mark Reid, Keneth Davies, Steven Laats, Duncan McArthur, Helen Feilden, Anna Marie Easson, Yasuko Kiyoi, Grant Wishart, Peter C. Ray	2011	2

About Peter C. Ray

Peter C. Ray is a scholar working on Infectious Diseases, Organic Chemistry, Computational Theory and Mathematics, Molecular Biology and Cancer Research, having authored 21 papers that have together received 556 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (8 papers), Computational Drug Discovery Methods (4 papers), Asymmetric Synthesis and Catalysis (4 papers), Mycobacterium research and diagnosis (3 papers), Synthetic Organic Chemistry Methods (3 papers), Biochemical and Molecular Research (3 papers), Chemical Synthesis and Reactions (2 papers) and Diagnosis and treatment of tuberculosis (2 papers). The work is most often cited by research in Infectious Diseases (284 citations), Molecular Medicine (52 citations), Organic Chemistry (162 citations), Epidemiology (179 citations) and Molecular Biology (256 citations). Peter C. Ray has collaborated with scholars based in United Kingdom, United States and South Africa. Frequent co-authors include Paul G. Wyatt, Clifton E. Barry, Helena I. Boshoff, Sophie Pelletier, Darren J. Dixon, Simon R. Green, Justin R. Harrison, Qinglan Wang, Stanley M. Roberts and Fabio Zuccotto. Their work appears in journals such as Tetrahedron Letters, ACS Infectious Diseases, Bioorganic & Medicinal Chemistry, Organic Letters and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact